Keyphrases
Aggressive Tumor
6%
All Clinical Trials
6%
Brachyury
6%
Chordoma
100%
Clinical Trial Design
6%
Clinical Trials
20%
Further Treatment
6%
Human Tumor Cells
6%
Immune Checkpoint Inhibitors
6%
Microenvironment
6%
Mobile Spine
6%
Notochord
6%
Patient Accrual
6%
Pazopanib
6%
Programmed Death-ligand 1 (PD-L1)
6%
Promising Areas
6%
PubMed
6%
Radiotherapy
6%
Recurrence Rate
6%
Skull Base
6%
Standard of Care
6%
Systemic Treatment
6%
Transforming Growth Factor-β
6%
Treatment Options
6%
Treatment Refractory
100%
Tyrosine Kinase Inhibitor
6%
Vaccine Types
6%
Ventromedial
6%
Viral Vectors
6%
Medicine and Dentistry
Autologous Tumor Cell
6%
Chordoma
100%
Clinical Trial
26%
Clinical Trial Design
6%
Immune Checkpoint Inhibitor
6%
Immunotherapy
100%
Neoplasm
6%
Notochord
6%
Pazopanib
6%
Programmed Death-Ligand 1
6%
Radiation Therapy
6%
Recurrence Risk
6%
Sacrum
13%
Skull Base
6%
Systemic Therapy
6%
Transforming Growth Factor Beta
6%
Tyrosine-Kinase Inhibitor
6%
Virus Vector
6%
Pharmacology, Toxicology and Pharmaceutical Science
Base
6%
Chordoma
100%
Clinical Trial
26%
Clinical Trial Design
6%
Immune Checkpoint Inhibitor
6%
Immunotherapy
100%
Neoplasm
13%
Pazopanib
6%
Protein Tyrosine Kinase Inhibitor
6%
Recurrence Risk
6%
Systemic Treatment
6%
Transforming Growth Factor Beta
6%
Viral Vector
6%
Neuroscience
Brachyury
6%
Chordoma
100%
Immunotherapy
100%
Notochord
6%
Pazopanib
6%
Radiation Therapy
6%
Skull Base
6%
Transforming Growth Factor Beta
6%
Tyrosine Kinase Inhibitor
6%
Vertebral Column
6%
Virus Vector
6%